Market Research Logo

US Market Report for X-Ray Imaging 2016 - MedCore

US Market Report for X-Ray Imaging 2016 - MedCore

In 2015, digital radiography X-rays were the largest segment, due to their increasing prevalence and popularity; many healthcare facilities prefer digital systems for their increased efficiency and image quality. While analog systems will continue to be sold at nominal levels over the forecast period, they will experience a rapid decline, almost disappearing from the market completely. Healthcare facilities are no longer purchasing analog systems. Even computed radiography is being gradually phased out due to rapid technological advancements in digital radiography. Digital systems offer faster scan times and produce digital images that are much easier to store than film-based images. The aging population will drive the cardiovascular X-ray segment, as this demographic is more likely to be diagnosed with conditions that require cardiac X-rays. Furthermore, despite lower unit sales of cardiovascular X-rays, this segment will maintain a sizeable share of the total market due to its higher ASP.The U.S. market for X-ray systems includes analog, computed radiography (CR), digital radiography (DR), fluoroscopy and cardiovascular X-ray systems. DR systems will continue to replace CR systems over the forecast period, while analog systems have almost completely disappeared from the market.


LIST OF FIGURES
LIST OF CHARTS
EXECUTIVE SUMMARY
U.S. MEDICAL IMAGING DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE CODES INVESTIGATED
PROCEDURES INCLUDED
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
PRODUCT ASSESSMENT
2.1 PRODUCT PORTFOLIOS
2.1.1 X-Ray Imaging
2.1.1.1 Introduction
2.1.1.2 Analog X-Ray Devices
2.1.1.3 Computed Radiography X-Ray Devices
2.1.1.4 Digital Radiography X-Ray Devices
2.1.1.5 Fluoroscopy Devices
2.1.1.6 Cardiovascular X-Ray Devices
2.2 REGULATORY ISSUES AND RECALLS
2.2.1 X-Ray Devices
2.3 CLINICAL TRIALS
2.3.1 Bayer
2.3.2 Bracco
2.3.3 Carestream Health
2.3.4 Fujifilm
2.3.5 GE Healthcare
2.3.6 Guerbet
2.3.7 Hologic
2.3.8 Lantheus Medical Imaging
2.3.9 Philips Healthcare
2.3.10 Siemens Healthcare
2.3.11 Toshiba Medical Systems
X-RAY IMAGING MARKET
3.1 MARKET OVERVIEW
3.2 MARKET ANALYSIS AND FORECAST
3.2.1 Analog X-Ray Market
3.2.2 Computed Radiography X-Ray Market
3.2.3 Digital Radiography X-Ray Market
3.2.4 Fluoroscopy Market
3.2.5 Cardiovascular X-Ray Market
3.3 DRIVERS AND LIMITERS
3.3.1 Market Drivers
3.3.2 Market Limiters
3.4 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
APPENDIX: COMPANY PRESS RELEASES
List of Charts
Chart 1 1: Medical Imaging Device Market by Segment, U.S., 2012 – 2022
Chart 1 2: Medical Imaging Device Market Overview, U.S., 2012 & 2022
Chart 3 1: X-Ray Imaging Market by Segment, U.S., 2012 – 2022
Chart 3 2: X-Ray Imaging Market Breakdown, U.S., 2015
Chart 3 3: X-Ray Imaging Market Breakdown, U.S., 2022
Chart 3 4: Analog X-Ray Market, U.S., 2012 – 2022
Chart 3 5: Computed Radiography X-Ray Market, U.S., 2012 – 2022
Chart 3 6: Digital Radiography X-Ray Market, U.S., 2012 – 2022
Chart 3 7: Fluoroscopy Market, U.S., 2012 – 2022
Chart 3 8: Cardiovascular X-Ray Market, U.S., 2012 – 2022
Chart 3 9: Leading Competitors, X-Ray Imaging Market, U.S., 2015
List of Figures
Figure 1 1: Medical Imaging Device Competitor Market Share Ranking by Segment, U.S., 2015 (1 of 2)
Figure 1 2: Medical Imaging Device Competitor Market Share Ranking by Segment, U.S., 2015 (2 of 2)
Figure 1 3: Companies Researched in this Report, U.S., 2015 (1 of 2)
Figure 1 4: Companies Researched in this Report, U.S., 2015 (2 of 2)
Figure 1 5: Factors Impacting the Medical Imaging Device Market by Segment, U.S. (1 of 2)
Figure 1 6: Factors Impacting the Medical Imaging Device Market by Segment, U.S. (2 of 2)
Figure 1 7: Recent Events in the Medical Imaging Device Market, U.S., 2012 – 2015
Figure 1 8: Procedure Codes Investigated, U.S., 2015 (1 of 3)
Figure 1 9: Procedure Codes Investigated, U.S., 2015 (2 of 3)
Figure 1 10: Procedure Codes Investigated, U.S., 2015 (3 of 3)
Figure 1 11: Medical Imaging Procedures Covered, U.S., 2015 (1 of 4)
Figure 1 12: Medical Imaging Device Markets Covered, U.S., 2015 (1 of 3)
Figure 1 13: Medical Imaging Device Markets Covered, U.S., 2015 (2 of 3)
Figure 1 14: Medical Imaging Device Markets Covered, U.S., 2015 (3 of 3)
Figure 1 15: Key Report Updates
Figure 1 16: Version History
Figure 2 1: Analog X-Ray Devices by Company
Figure 2 2: Computed Radiography X-Ray Devices by Company
Figure 2 3: Computed Radiography X-Ray Devices by Company (1 of 2)
Figure 2 4: Computed Radiography X-Ray Devices by Company (2 of 2)
Figure 2 5: Fluoroscopy Devices by Company
Figure 2 6: Cardiovascular X-Ray Devices by Company (1 of 2)
Figure 2 7: Cardiovascular X-Ray Devices by Company (2 of 2)
Figure 2 8: Class 2 Device Recall Philips Xray
Figure 2 9: Class 2 Device Recall GE Precision Mpi
Figure 2 10: Class 2 Device Recall Allura Xper Systems
Figure 2 11: Class 2 Device Recall INFX8000V
Figure 2 12: Class 2 Device Recall Philips
Figure 2 13: Class 2 Device Recall TraumaDiagnost
Figure 2 14: Class 2 Device Recall Allura Xper, Clarity, INTEGRIS series
Figure 2 15: Class 2 Device Recall System, Xray, Fluroscopic
Figure 2 16: Class 2 Device Recall Optima IGS 320
Figure 2 17: Class 2 Device Recall Optima CL323i
Figure 2 18: Class 2 Device Recall Philips BuckyDiagnost ; Model: 704060/706037
Figure 2 19: Class 2 Device Recall Philips EasyDiagnost ; Model: 706050
Figure 2 20: Class 2 Device Recall Philips Healthcare
Figure 2 21: Class 2 Device Recall CIOS ALPHA
Figure 2 22: Class 2 Device Recall Carestream DRXEVOLUTION
Figure 2 23: Class 2 Device Recall Artis zee/ zeego systems
Figure 2 24: Class 2 Device Recall Artis Q systems
Figure 2 25: Class 2 Device Recall Axiom Artis systems
Figure 2 26: Class 2 Device Recall GE Healthcare Precision RXi 23A/32A Analog System
Figure 2 27: Class 2 Device Recall GE Healthcare Precision RXi Digital system
Figure 2 28: Class 2 Device Recall GE Healthcare Discovery IGS 740 & IGS Innova series
Figure 2 29: Class 2 Device Recall GE Healthcare Optima CL 323i
Figure 2 30: Class 2 Device Recall Cios Alpha
Figure 2 31: Class 2 Device Recall Artis zee/ zeego systems
Figure 2 32: Class 2 Device Recall AGFA Digital Radiography Xray system DXD 100
Figure 2 33: Class 2 Device Recall SIEMENS Axiom Luminos dRF Max
Figure 2 34: Class 2 Device Recall SIEMENS Ysio Max
Figure 2 35: Class 2 Device Recall Philips Healthcare DuraDiagnost X Ray
Figure 2 36: Class 2 Device Recall AXIOM ARISTOS FX
Figure 2 37: Class 2 Device Recall Artis Q/ Q zen systems see related information
Figure 2 38: Class 2 Device Recall CAT880B catheterization table for the Toshiba Infinix Xray Interventional System (INFX8000V/U7)
Figure 2 39: Class 2 Device Recall Philips Heatlhcare
Figure 2 40: Class 2 Device Recall GE Healthcare Proteus XR/a
Figure 2 41: Class 2 Device Recall Allura Xper XRay Angiographic
Figure 2 42: Class 2 Device Recall Multi Diagnost Eleva II & Philips Multi Diagnost Eleva with FlatDetector
Figure 2 43: Class 2 Device Recall Artis One
Figure 2 44: Class 2 Device Recall Ysio Max, Luminos dRF Max and Agile Max systems
Figure 2 45: Class 2 Device Recall GE Healthcare, Discovery IGS 730 & Discovery IGS 740
Figure 2 46: Class 2 Device Recall Artis zee/ zeego systems
Figure 2 47: Class 2 Device Recall Proteus XR/a
Figure 2 48: Class 2 Device Recall Innova IGS 540
Figure 2 49: Class 2 Device Recall GE Healthcare Discovery IGS 740
Figure 2 50: Class 2 Device Recall GE Healthcare Innova 4100IQ
Figure 2 51: Class 2 Device Recall Siemens Artis zee and zeego systems
Figure 2 52: Class 2 Device Recall Siemens Artis zeego systems
Figure 2 53: Class 2 Device Recall Series OEC 9800 & OEC UroView 2800
Figure 2 54: Class 2 Device Recall Philips Medical Systems Allura Xper FD20C
Figure 2 55: Class 2 Device Recall Integris Allura Radiograph / Fluoroscopy x ray system
Figure 2 56: Class 2 Device Recall Siemens Uroskop Omnia Max system
Figure 2 57: Class 2 Device Recall Siemens AXIOM Luminos dRF Max system
Figure 2 58: Class 2 Device Recall Siemens Ysio Max system
Figure 2 59: Class 2 Device Recall Siemens Luminos Agile Max system
Figure 2 60: Class 2 Device Recall Siemens AXIOM Artis or Artis zee system
Figure 2 61: Class 2 Device Recall The Ysio Systems with software version VC10
Figure 2 62: Class 2 Device Recall Siemens
Figure 2 63: Class 3 Device Recall Agfa Digital Radiography XRay System DXD 100
Figure 2 64: Class 2 Device Recall Kodak DirectView DR 7500 Diagnostic XRay System
Figure 2 65: Class 2 Device Recall DXD 600
Figure 2 66: Class 2 Device Recall KODAK DirectView DR 9000 System
Figure 2 67: Class 2 Device Recall AGFA Digital Radiography XRay system DXD 100
Figure 2 68: Class 2 Device Recall Proteus XR/a
Figure 2 69: Class 2 Device Recall Revolution XR/d
Figure 2 70: Class 2 Device Recall Siemens RAD Fluoro Uro
Figure 2 71: Class 2 Device Recall Siemens
Figure 2 72: Class 2 Device Recall Shimadzu Digital Radiography XRay System, DAR8000f
Figure 2 73: Class 2 Device Recall Siemens MULTIX FUSION see related information
Figure 2 74: Class 2 Device Recall OEC 9900 Elite
Figure 2 75: Class 2 Device Recall Siemens Artis Zee Family
Figure 2 76: Class 2 Device Recall Siemens
Figure 2 77: Class 2 Device Recall Siemens
Figure 2 78: Class 2 Device Recall Xray System
Figure 2 79: Class 2 Device Recall Siemens Artis zee Ceiling Systems
Figure 2 80: Class 2 Device Recall Precision 500D R&38;F Xray System
Figure 2 81: Class 2 Device Recall Carestream DRX Evolution System
Figure 2 82: Class 2 Device Recall IGS 630
Figure 2 83: Class 2 Device Recall KODAK DirectView DR 7500 Dual Detector System, MODEL DR 7500
Figure 2 84: Class 2 Device Recall Easy Diagnost Eleva
Figure 2 85: Class 2 Device Recall Siemens Rad Fluoro Uro Systems
Figure 2 86: Class 2 Device Recall Siemens Artis zee systems
Figure 2 87: Class 2 Device Recall Siemens RAD Fluoro Uro Systems
Figure 2 88: Class 2 Device Recall GE Healthcare
Figure 2 89: Class 2 Device Recall GE Healthcare Discovery IGS 730 Cardiovascular XRay Imaging System
Figure 2 90: Class 2 Device Recall Siemens Axiom Artis
Figure 2 91: Class 2 Device Recall Radiographic system, digital
Figure 2 92: Class 2 Device Recall MobileDiagnost wDR
Figure 2 93: Class 2 Device Recall Carestream DRX Evolution System
Figure 2 94: Class 2 Device Recall Siemens AXIOM Artis zeego
Figure 2 95: Class 2 Device Recall ARTIS zee and zeego
Figure 2 96: Class 2 Device Recall Siemens AXIOM Artis zee/zeego systems equipped with generator A100 Plus
Figure 2 97: Class 2 Device Recall GE Healthcare, Innova 3100 and Innova 4100 systems
Figure 2 98: Class 2 Device Recall Philips Bucky Diagnost
Figure 2 99: Class 2 Device Recall Fluoroscan Mini Carm InSight2
Figure 2 100: Class 2 Device Recall GE Healthcare
Figure 2 101: Class 2 Device Recall GE Healthcare
Figure 2 102: Class 2 Device Recall Artis Systems
Figure 2 103: Class 2 Device Recall Siemens Axiom Artis zeego systems
Figure 2 104: Class 2 Device Recall GE Healthcare
Figure 2 105: Class 2 Device Recall GE Healthcare
Figure 2 106: Class 2 Device Recall Phillips Easy Diagnost Elva DRF
Figure 2 107: Class 2 Device Recall GE Healthcare innova 3100 series & 3131-IQ
Figure 2 108: Class 2 Device Recall GE Healthcare
Figure 2 109: Class 2 Device Recall Philips Essenta DR, XRay System
Figure 2 110: Class 2 Device Recall Philips
Figure 2 111: Class 2 Device Recall Philips Multi Diagnost Eleva II with swivel cable
Figure 2 112: Class 2 Device Recall Silhouette FC
Figure 2 113: Class 2 Device Recall Allura Xray system
Figure 2 114: Class 2 Device Recall Philips Healthcare MD Eleva system
Figure 2 115: Class 2 Device Recall Philips Healthcare EasyDiagnost Eleva DRF 4.0
Figure 2 116: Class 2 Device Recall GE Healthcare Innova
Figure 2 117: Class 2 Device Recall Philips
Figure 2 118: Class 2 Device Recall Philips MultiDiagnost Eleva FD
Figure 2 119: Class 2 Device Recall Philips MultiDiagnost Eleva II Software Version R4.1
Figure 2 120: Class 2 Device Recall REVOLUTION XR/D DIGITAL RADIOGRAPHIC IMAGING SYSTEM WITH TOMOSYNTHESIS
Figure 2 121: Class 2 Device Recall Philips MultiDiagnost Eleva IITV
Figure 2 122: Class 2 Device Recall Philips MultiDiagnost Eleva FD
Figure 2 123: Class 2 Device Recall Definium 8000
Figure 2 124: Class 2 Device Recall Discovery XR650
Figure 2 125: Perfusion CT as a Predictor for Response to Antiangiogenic Therapy
Figure 2 126: A Multicenter Study of Iomeron®-400
Figure 2 127: Retrospective Study of MRI in Pediatric Patients
Figure 2 128: A Pilot Trial Using BR55 Ultrasound Contrast Agent
Figure 2 129: Crossover Comparison of MultiHance and Dotarem (BENEFIT)
Figure 2 130: Multidetector Computed Tomography (MDCT) Tailored Protocol
Figure 2 131: Reproducibility and Repeatability of Multifunctional MRI Biomarkers of the Body
Figure 2 132: Reproducibility and Repeatability of Multifunctional MRI Biomarkers of the Body
Figure 2 133: CARESTREAM Vue PACS v12.1.5 CT Perfusion Clinical Protocol (CTP)
Figure 2 134: Clinical Evaluation of CARESTREAM Dual Energy and Digital Tomosynthesis
Figure 2 135: Clinical Evaluation of the Carestream PRO 3543 and PRO 3543C Digital Detectors
Figure 2 136: Clinical Evaluation of DRX Plus 3543 and DRX Plus 3543C Digital Detectors
Figure 2 137: Carestream Digital Radiography Long Length Imaging Software Data Collection Protocol (LLI-MSE)
Figure 2 138: A Multi-Reader Multi-Case Pivotal Trial
Figure 2 139: Pilot Mammography Reader Study
Figure 2 140: Acquisition of Breast Mammography Images
Figure 2 141: Study Comparing Flexible Spectral-Imaging Color Enhancement (FICE) With Olympus Narrow Band Imaging (NBI)
Figure 2 142: Pilot 3D Mammography Reader Study to Assess Breast Cancer Detection
Figure 2 143: Pilot Study Comparing Diagnostic Imaging Versus Tomosynthesis in Detection of Hip, Wrist or Tibia Injury (TOMO)
Figure 2 144: Collection of FUJIFILM's 3Dimensional Mammograms (3DM)
Figure 2 145: International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients
Figure 2 146: Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2 (mTBI-phase2)
Figure 2 147: Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis
Figure 2 148: Non-invasive Quantification of Liver Iron With MRI
Figure 2 149: Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis
Figure 2 150: Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis
Figure 2 151: Development of a MR Scanner Capable of Being Sited in a Neonatal Intensive Care Unit (Firefly)
Figure 2 152: Phase 4 Study to Demonstrate Prognostic Usefulness of AdreView™ Scintigraphy
Figure 2 153: Clinical Evaluation of an Integrated PET/MRI System (PET/MR_ZURICH)
Figure 2 154: Automated Breast Ultrasound and Digital Breast Tomosynthesis Screening
Figure 2 155: Development of an Integrated PET/MR System, Accessories and Components
Figure 2 156: Comparison of 18F FDG PET/CT TO PET MRI (PET/MR US)
Figure 2 157: Compare Rates of Agreement Between Clinical Diagnosis and Visual Assessment of DaTscan™ Images
Figure 2 158: Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView
Figure 2 159: Clinical Evaluation for GE CT System
Figure 2 160: A Case Collection Study for Digital Breast Tomosynthesis (DBT)
Figure 2 161: Assess Safety, Bio-distribution, Radiation Dosimetry and Optimize the Imaging Protocol of GEH120714 (18F) Injection
Figure 2 162: Magnetic Resonance Imaging Using Innovative Pulse Sequences
Figure 2 163: MRI Scanning of People With MR Safe Orthopedic Implants That Are Made of Metal (MRI)
Figure 2 164: Contrast Ultrasound Detection of Sentinel Lymph Nodes
Figure 2 165: Feasibility of Short Breast MRI (SBMRI) for Screening Patients at High Risk for Breast Cancer
Figure 2 166: PET/CT for Staging Rectal Cancer Patients With and Without EMVI-MR
Figure 2 167: Contrast Enhanced Spectral Mammography (CESM) Study (CONTEND)
Figure 2 168: Assessment of Automated Breast Ultrasound
Figure 2 169: Feasibility of Ultrasound Microbubble Contrast-Enhanced (CEUS) Sentinel Lymph Node Imaging
Figure 2 170: How Beta-amyloid Imagining Influences Clinician Diagnosis and Management
Figure 2 171: Dual-Energy CT in Patients With Head and Neck Squamous Cell Carcinomas
Figure 2 172: Use of MIBG Scan Images in PVC Ablations (PVC-MIBG)
Figure 2 173: Comparison of Contrast-enhanced Spectral Mammography (CESM) to MRI
Figure 2 174: Fluoro-L-Thymidine Positron Emission Tomography (FLT PET) vs. Adv. Magnetic Resonance (MR) Techniques
Figure 2 175: A Pilot, Exploratory, Non-Randomized Study of PET/CT With the Investigational Agent [18F] Fluciclatide
Figure 2 176: 123I-mIBG SPECT Imaging
Figure 2 177: Preoperative Staging and Dose Escalated Radiotherapy of Prostate Carcinoma With PET and MRI (Flucipro)
Figure 2 178: FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients
Figure 2 179: The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From Malignant Breast Disease
Figure 2 180: Imaging Biomarkers of Delayed Sequelae in Trauma Brain Injury
Figure 2 181: Safety and Efficacy of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization (In-Live)
Figure 2 182: P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)
Figure 2 183: Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI
Figure 2 184: Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI
Figure 2 185: Evaluation of Gadoterate in Patients With Decreased Kidney Function
Figure 2 186: Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer
Figure 2 187: Hepatic Xenetix-CT Perfusion
Figure 2 188: Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis
Figure 2 189: Pancreatic Duct Evaluation in Autoimmune Pancreatitis: MR Pancreatography
Figure 2 190: Computed Tomography Versus Standard 2D Mammography Versus 3D Tomosynthesis
Figure 2 191: Open Label Study to Access Flurpiridaz F18 in PET MPI Verses SPECT MPI
Figure 2 192: Virtual Path Planning for Image-guided Needle Interventions
Figure 2 193: Applications of Dual-Energy Computed Tomography
Figure 2 194: X-ray Dose Reduction Study for Cardiac Angiography and Intervention
Figure 2 195: X-ray Dose Reduction Study for Endovascular Interventional Radiology
Figure 2 196: X-ray Dose Reduction in Electrophysiology
Figure 2 197: Multicenter Study of Magnetic Resonance-guided High Intensity Focused Ultrasound
Figure 2 198: MRI/TRUS Fusion Guided Prostate Biopsy- An Improved Way to Detect and Quantify Prostate Cancer
Figure 2 199: Sonalleve Fibroid Ablation Pivotal Clinical Trial for MR-HIFU of Uterine Fibroids (SOFIA)
Figure 2 200: Cardiovascular Magnetic Resonance-Guided Radiofrequency-Ablation for Atrial Flutter
Figure 2 201: Percutaneous Closure of Atrial Septal Defects in Children
Figure 2 202: Assessment of 3D Transperineal Ultrasound Imaging w/ Matrix Array Transducers in Prostate Radiotherapy
Figure 2 203: Radio Frequency Ablation for Atrial Flutter With Magnetic Resonance Guidance and Tracking
Figure 2 204: Chest Ultrasound of ER Patients With Cough or SOB
Figure 2 205: The Value of MultiSpectral 3 Tesla MRI in Active Surveillance of Prostate Cancer
Figure 2 206: Multi Modal Cardiac Imaging Prior Transcatheter Aortic Valve Implantation
Figure 2 207: MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases
Figure 2 208: Evaluation of Diagnostic Accuracy of Contrast Enhanced Dual Energy Mammography Imaging
Figure 2 209: Evaluation of an Innovative Medical Device Supporting Orthopedic Surgical Interventions (VIPS)
Figure 2 210: PET/MRI in Patients With Suspected Prostate Cancer
Figure 2 211: Perfusion CT as a Predictor for Response to Antiangiogenic Therapy
Figure 2 212: Verification of the Quantitative Accuracy of the PET/CT System Imaging Chain
Figure 2 213: General Investigative MRI Protocol
Figure 3 1: X-Ray Imaging Market by Segment, U.S., 2012 – 2022 (US$M)
Figure 3 2: Analog X-Ray Market, U.S., 2012 – 2022
Figure 3 3: Computed Radiography X-Ray Market, U.S., 2012 – 2022
Figure 3 4: Digital Radiography X-Ray Market, U.S., 2012 – 2022
Figure 3 5: Fluoroscopy Market, U.S., 2012 – 2022
Figure 3 6: Cardiovascular X-Ray Market, U.S., 2012 – 2022
Figure 3 7: Drivers and Limiters, X-Ray Imaging Market, U.S., 2015
Figure 3 8: Leading Competitors, X-Ray Imaging Market, U.S., 2015
Figure 5 1: Press Release Summary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report